A polarimetric study was made of the interaction of the tetramminecopper (TACu) reagent and the Cupra B reagent with bluensomycin, desamidinodecarbamoyl (DADC) bluensomycin, and several reference compounds of the streptomycin series. The results obtained with TACusupport the choice of 5b as the correct formula for DADC-bluensomycin.
A polarimetric study was made of the interaction of the tetramminecopper (TACu) reagent and the Cupra B reagent with bluensomycin, desamidinodecarbamoyl (DADC) bluensomycin, and several reference compounds of the streptomycin series. The results obtained with TACusupport the choice of 5b as the correct formula for DADC-bluensomycin.
It follows that bluensomycin is 9, and bluensidine is lD~l-O-carbamoyl-3-deoxy-3-guanidinosc3/ZZo-inositol (2 the absolute configuration of the partial structure involved. Cupra B has been used to determine the stereochemical details of the structures of a number of aminoglycoside antibiotics4'5'*0.
However, because of the tendency of this reagent to complex with vicinal glycols it has been necessary to degrade the antibiotics extensively to partially blocked streptamine or deoxystreptamine derivatives. The conversion of bluensomycin to a substance with a complexing site for TAGu in the cyclitol moiety was accomplished with hot barium hydroxide. The product, desamidinodecarbamoylbluensomycin (DADG-bluensomycin) must have one of the formulas 5b~8b. Also prepared as a comparison substance of knownstereochemistry was the barium hydroxide hydrolysis product of dihydrostreptomycin7'8), which we designate didesamidinodihydrostreptomycin (DDA-dihydrostreptomycin, 3)****. In addition, because the N-methyl-L-glucosamine unit of bluensomycin has a site for complexing with TACu it was deemed important to examine degradation products containing this unit, but not the cyclitol.
The known compounds methyl dihydrostreptobiosaminide and methyl N-methyl-L-glucosaminide were accordingly prepared from dihydrostreptomycin. The optical rotatory data obtained with all of these compoundsin water, TACu, *** Abbreviations used are : TACu,tetramminecopper reagent; DADC, desamidinodecarbamoyl; DDA,didesamidino.
**** Other authors have termed this substance "dideguanyldihydrostreptomycin". Table 2 . For fqrmulas 5b and 8b the calculation is straightforward, there being one site for complexing in the cyclitol moiety in each case, "positive" for 5b and "negative" for 8b. It is assumed that both this site and the site in the N-methyl-Lglucosamine unit will be occupied.
On the other hand the cyclitol unit in formulas 6b and 7b has both a positive site and a negative site, only one of which can be occupied at any given time. If it is assumed, for the moment, that these sites have equal probability of occupancy, then complexing at the cyclitol unit would make
It may be seen ( 
Optical Rotatory Measurements
The TACureagent was made by dissolving tetramminecopper(II) sulfate12) in water in the proportion 3.95g per 100ml. Cupra B was prepared as described by Reeves13).
Solutions were made up in water or the desired copper reagent, and their rotations were observed at 436 nm with a Perkin-Elmer model 141 photoelectric polarimeter.
